Lithium-carbamazepine neurotoxicity and risk factors

Abstract
Five rapid-cycling manic patients developed neurotoxic syndromes when treated with a combination of Li and carbamazepine, although all 5 had therapeutic plasma levels of both drugs. The risk factors for development of neurotoxicity with this drug combination are discussed.

This publication has 6 references indexed in Scilit: